Atlas Venture Associates Opportunity I, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/02/09

Trade details

Type: Insider sale
Amount: $469.12
Shares · price: 733 sh · $0.64 a share
Held after: 2,019,563 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Associates Opportunity I10% Owner
Trade date: 24/02/08
Filed: 24/02/09
Days to filing: 1 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/09~24/03/09

Atlas Venture Associates Opportunity I's recent trades

Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$5.3M
126,066 sh
$5.3M
Filed 24/03/13
Traded 24/03/12
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$4.6M
108,404 sh
$4.6M
Filed 24/03/13
Traded 24/03/13
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.6M
37,180 sh
$1.6M
Filed 24/03/13
Traded 24/03/11
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.1M
26,452 sh
$1.1M
Filed 24/03/13
Traded 24/03/12
Atlas Venture Associates Opportunity I10% Owner
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$961K
22,779 sh
$961K
Filed 24/03/13
Traded 24/03/13